Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2020		Jun. 30, 2019
U.S. Equity Cumulative Dividends Fund-Series 2027
Cash Flows from operating activities
Net increase/(decrease) in net assets from operating activities	$ (3,756,782)		$ 489,361
Adjustments to reconcile net increase/(decrease) in net assets from operations to net cash provided by (used in) operating activities:
Purchases of investments	(17,323,425)		(21,723,072)
Proceeds from sale of investments	23,621,014		2,754,692
Accretion of discounts and amortization of premiums	90,412		(2,622)
Net realized (gain)/loss on investments	(1,179,977)		(23,297)
Net change in unrealized (appreciation)/depreciation on investments	(51,607)		(92,262)
(Increase)/decrease in operating assets
Cash pledged as collateral on futures contracts			(146,119)
Interest receivable	20,948		(147,259)
Receivable from advisor			15,459
Variation margin receivable on open futures contracts	(123,000)		(65,000)
Deferred offering costs			21,234
Increase/(decrease) in operating liabilities
Due to advisor	(4,458)		(12,080)
Payable to administrator			(3,185)
Payable to Transfer Agent			1,445
Payable to Trustees			13,293
Payable for Professional Fees			58,737
Variation margin payable on open futures contracts	(20,500)		(28,500)
Other accrued expenses	(18,157)		(177,208)
Net cash provided by (used in) operating activities	1,254,468		(19,066,383)
Cash Flows from financing activities
Proceeds from capital share issuances			20,739,281
Capital share redemptions			(1,195,534)
Distributions to shareholders	(1,419,625)		(224,000)
Net cash provided by (used in) financing activities	(1,419,625)		19,319,747
Net change in cash and cash equivalents	(165,157)		253,364
Cash, cash equivalents and restricted cash, beginning of period	1,054,845		212,744
Cash, cash equivalents and restricted cash, end of period	889,688		466,108
Supplemental Disclosure of Cash Flow and Non-Cash Information:
Income Distribution Payable	312,625		250,000
U.S. Equity Ex-Dividend Fund-Series 2027
Cash Flows from operating activities
Net increase/(decrease) in net assets from operating activities	(120,930)		2,625,237
Adjustments to reconcile net increase/(decrease) in net assets from operations to net cash provided by (used in) operating activities:
Purchases of investments	(35,761,942)		(48,772,934)
Proceeds from sale of investments	35,971,964		36,901,929
Accretion of discounts and amortization of premiums	(108,024)		(166,412)
Net realized (gain)/loss on investments	(49,941)		(7,389)
Net change in unrealized (appreciation)/depreciation on investments	260		(5,400)
(Increase)/decrease in operating assets
Cash pledged as collateral on futures contracts			602,076
Receivable from advisor			14,042
Variation margin receivable on open futures contracts	(344,000)		4,813
Deferred offering costs			19,259
Increase/(decrease) in operating liabilities
Due to advisor	(292)		(7,921)
Payable for securities purchased	499,721
Payable to administrator			(3,185)
Payable to Transfer Agent			1,420
Payable to Trustees			13,293
Payable for Professional Fees			58,747
Variation margin payable on open futures contracts	24,000		13,000
Other accrued expenses	(23,887)		(172,735)
Net cash provided by (used in) operating activities	86,929		(8,882,160)
Cash Flows from financing activities
Proceeds from capital share issuances			8,968,870
Net cash provided by (used in) financing activities			8,968,870
Net change in cash and cash equivalents	86,929		86,710
Cash, cash equivalents and restricted cash, beginning of period	1,134,308		69,630
Cash, cash equivalents and restricted cash, end of period	$ 1,221,237	[1]	$ 156,340

[1] Agrees to the total of Cash and Cash equivalents" and "Cash pledged as collateral for futures contracts" balances on the Statements of Financial Condition.